Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclacel Pharmaceuticals

0.3200
+0.02046.81%
Post-market: 0.32000.00000.00%19:14 EDT
Volume:297.19K
Turnover:89.51K
Market Cap:3.60M
PE:-0.05
High:0.3200
Open:0.2986
Low:0.2912
Close:0.2996
Loading ...

BRIEF-Cyclacel Pharmaceuticals Says Datuk Dr.Doris Wong Sing Ee Elected As CEO & Executive Director

Reuters
·
28 Feb

Cyclacel Pharmaceuticals Inc - Kiu Cu Seng Appointed as Executive Director, Secretary and CFO

THOMSON REUTERS
·
28 Feb

Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership

THOMSON REUTERS
·
28 Feb

Cyclacel Pharmaceuticals Inc - Datuk DR. Doris Wong Sing Ee Elected as CEO and Executive Director

THOMSON REUTERS
·
28 Feb

Cyclacel Pharmaceuticals Inc - David Lazar Resigns as Interim CEO and Secretary

THOMSON REUTERS
·
28 Feb

BRIEF-Cyclacel Pharmaceuticals Announces Creditors Voluntary Liquidation Of UK Subsidiary

Reuters
·
06 Feb

Cyclacel Pharmaceuticals Inc - Announces Creditors Voluntary Liquidation of UK Subsidiary

THOMSON REUTERS
·
06 Feb

Cyclacel Pharmaceuticals Inc - to Purchase Plogosertib From Liquidators

THOMSON REUTERS
·
06 Feb

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires Live
·
04 Jan

Cyclacel Pharmaceuticals Says David Lazar Buys $3.1 Million in Preferred Stock, Becomes Interim CEO

MT Newswires Live
·
03 Jan

BRIEF-Cyclacel Pharma Announces Agreement For The Acquisition Of Preferred Stock By David Lazar

Reuters
·
03 Jan

Cyclacel announces agreement for acquisition of preferred stock

TIPRANKS
·
03 Jan

Cyclacel Pharmaceuticals Inc - Spiro Rombotis Steps Down as CEO, David Lazar Appointed Interim CEO

THOMSON REUTERS
·
03 Jan

Cyclacel Pharmaceuticals Inc - Board Directs Management to Reduce Operating Costs

THOMSON REUTERS
·
03 Jan

Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar

THOMSON REUTERS
·
03 Jan